Skin thickness in young infants and adolescents: Applications for intradermal vaccination

Vaccine

Volumn 33, Issue 29, 2015, Pages 3384-3391

  Saitoh, Akihiko ^a   Aizawa, Yuta ^a   Sato, Isamu ^b   Hirano, Harunobu ^c   Sakai, Takatsugu ^d   Mori, Masaaki ^e  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Yoiko no Syonika Sato Clinic   (Japan)

^c Saiseikai Niigata Daini Hospital   (Japan)

^d Niigata Medical University   (Japan)

^e YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Adolescent; Deltoid; Infant; Intradermal injection; Skin thickness; Suprascapular

Indexed keywords

INFLUENZA VACCINE; VACCINE;

ADOLESCENT; ARTICLE; BODY WEIGHT; DELTOID MUSCLE; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; IMMUNOGENICITY; INFANT; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NEEDLE; PRIORITY JOURNAL; SKINFOLD THICKNESS; VACCINATION; ANATOMY AND HISTOLOGY; ANTHROPOMETRY; DEVICES; INTRADERMAL DRUG ADMINISTRATION; JAPAN; PROCEDURES; SKIN;

ADOLESCENT; ANTHROPOMETRY; FEMALE; HUMANS; INFANT; INJECTIONS, INTRADERMAL; JAPAN; MALE; SKIN; ULTRASONOGRAPHY; VACCINATION; VACCINES;

EID: 84931571662     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.04.081     Document Type: Article

References (25)

1. Kupper T.S., Fuhlbrigge R.C. Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 2004, 4:211-222.
2. Program for Appropriate Technology in Health (PATH) Intradermal delivery of vaccines: a review of the literature and potential for development for use in low- and middle-income countries. 27 August 2009, Available at: http://www.path.org/publications/files/TS_opt_idd_review.pdf [accessed 10.04.14].
3. Chau K.F., Cheng Y.L., Tsang D.N., Choi K.S., Wong K.M., Chak W.L., et al. Efficacy and side effects of intradermal hepatitis B vaccination in CAPD patients: a comparison with the intramuscular vaccination. Am J Kidney Dis 2004, 43:910-917.
4. Young F., Marra F. A systematic review of intradermal influenza vaccines. Vaccine 2011, 29:8788-8801.
5. Kenny R.T., Frech S.A., Muenz L.R., Villar C.P., Glenn G.M. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 2004, 351:2295-2301.
6. Flynn P.M., Shenep J.L., Mao L., Crawford R., Williams B.F., Williams B.G. Influence of needle gauge in Mantoux skin testing. Chest 1994, 106:1463-1465.
7. Mitragotri S. Immunization without needles. Nat Rev Immunol 2005, 5:905-916.
8. Atmar R.L., Patel S.M., Keitel W.A. Intanza((R)): a new intradermal vaccine for seasonal influenza. Expert Rev Vaccines 2010, 9:1399-1409.
9. Laurent P.E., Bonnet S., Alchas P., Regolini P., Mikszta J.A., Pettis R., et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 2007, 25:8833-8842.
10. Laurent A., Mistretta F., Bottigioli D., Dahel K., Goujon C., Nicolas J.F., et al. Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines. Vaccine 2007, 25:6423-6430.
11. Ploin D., Schwarzenbach F., Dubray C., Nicolas J.F., Goujon C., Trong M.D., et al. Echographic measurement of skin thickness in sites suitable for intradermal vaccine injection in infants and children. Vaccine 2011, 29:8438-8442.
12. WHO recommendations on Rabies post-exposure treatment and the correct technique of intradermal immunization against rabies. WHO/EMC/ZOO/96.6 1996, Available at: http://whqlibdoc.who.int/hq/1996/WHO_EMC_ZOO_96.6.pdf [accessed 23.01.15].
13. Arnou R., Icardi G., De Decker M., Ambrozaitis A., Kazek M.P., Weber F., et al. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine 2009, 27:7304-7312.
14. ® 9μg intradermal seasonal influenza vaccine for adults 18 to 59 years of age. Vaccines Immunother 2013, 9:115-121.
15. Publication WHO Rabies vaccines: WHO position paper. Wkly Epidemiol Rec 2010, 85:309-320.
16. Chiu S.S., Chan K.H., Tu W., Lau Y.L., Peiris J.S. Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: a randomized controlled trial. Vaccine 2009, 27:4834-4839.
17. Sugimura T., Ito Y., Tananari Y., Ozaki Y., Maeno Y., Yamaoka T., et al. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination. Vaccine 2008, 26:2700-2705.
18. Chiu S.S., Peiris J.S., Chan K.H., Wong W.H., Lau Y.L. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Pediatrics 2007, 119:1076-1082.
19. Milne A., Allwood G.K., Pearce N.E., Lucas C.R., Krugman S. Low dose hepatitis B vaccination in children. N Z Med J 1986, 99:47-49.
20. Beran J., Ambrozaitis A., Laiskonis A., Mickuviene N., Bacart P., Calozet Y., et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med 2009, 7:13.
21. Seidenari S., Giusti G., Bertoni L., Magnoni C., Pellacani G. Thickness and echogenicity of the skin in children as assessed by 20-MHz ultrasound. Dermatology 2000, 201:218-222.
22. Du Bois D., Du Bois E.F. A formula to estimate the approximate surface area if height and weight be known 1916. Nutrition 1989, 5:303-311.
23. Kuczmarski R.J., Ogden C.L., Guo S.S., Grummer-Strawn L.M., Flegal K.M., Zuguo M., et al. 2000 CDC Growth charts for the United States: method and development. Vital Health Stat 11 2002, 246:1-190.
24. Saitoh A., Okabe N. Current issues with the immunization program in Japan: can we fill the "vaccine gap"?. Vaccine 2012, 30:4752-4756.
25. Hung I.F.N., Levin Y., To K.K.W., Chan K.H., Zhang A.J., Li P., et al. Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain. Vaccine 2012, 30:6427-6435. http://webbook.nist.gov/cgi/cbook.cgi?Name=Isoprene&Units=SI&cMS=on.